Vivimed Labs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs Limited has filed its financial results with the NSE for the quarter and half-year ended September 30, 2025. The filing itself is only a submission notice and does not contain the actual numbers, segment breakdown, or audit observations in this announcement text. Investors would need to refer to the detailed results PDF or the company's BSE/NSE filings for revenue, profit, margin, and cash flow figures. No commentary from management or auditor remarks are included in this notice.
Neutral from a market perspective — this is a routine regulatory submission confirming timely filing of quarterly results. The actual impact on the stock will depend on the numbers in the detailed results, which are not disclosed in this announcement.